In Thursday’s Wall Street session, Astera Labs Inc (NASDAQ:ALAB) shares traded at $71.64, up 0.77% from the previous session.
ALAB stock price is now 10.05% away from the 50-day moving average and -6.97% away from the 200-day moving average. The market capitalization of the company currently stands at $11.81B.
With the price target of $82, Raymond James recently initiated with Outperform rating for Astera Labs Inc (NASDAQ: ALAB). On January 28, 2025, Northland Capital Upgraded its previous ‘Market Perform’ rating to ‘Outperform’ on the stock keeping its target price maintained at $120, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, RN2021 IRREVOCABLE TRUST U/A D, Director bought 20,000 shares of the company’s stock on May 08 ’25. The stock was bought for $1,421,800 at an average price of $71.09. An SEC document containing details of the transaction can be found on the SEC’s website. On May 08 ’25, Director NAVAD TRUST U/A DTD 11/01/2012 bought 125,000 shares of the business’s stock. A total of $8,886,250 was incurred on buying the stock at an average price of $71.09. A total of 24.81% of the company’s stock is owned by insiders.
During the past 12 months, Astera Labs Inc has had a low of $36.22 and a high of $147.39. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 13.92, and a quick ratio of 13.26.
The net profit margin was 8.44% and return on equity was 4.47% for ALAB. The company reported revenue of $159.44 million for the quarter, compared to $65.26 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 144.33 percent.
